Keros Therapeutics, Inc. — Form D
Keros Therapeutics, Inc. of LEXINGTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-11-21. The offering totals $23.0M, of which $11.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-11-21
- Form: D
- Accession: 0001664710-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $23.0M
- Amount sold: $11.5M
- Remaining: $11.5M
- Investors: 9
- Date of first sale: 2018-11-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-326320
Issuer
- Name: Keros Therapeutics, Inc.
- CIK: 0001664710
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 99 HAYDEN AVENUE, LEXINGTON, MA, 02421
- Phone: 617-513-8774
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Zafrira S Avnur | Director | Lexington, MA |
| Ohad S Hammer | Director | Lexington, MA |
| Julius S Knowles | Director | Lexington, MA |
| Alon S Lazarus | Director | Lexington, MA |
| Ran S Nussbaum | Director | Lexington, MA |
| Jasbir S Seehra | Director | Lexington, MA |
| Jasbir S Seehra | Executive Officer | Lexington, MA |
| CARL GORDON | Director | SAN DIEGO, CA |
| Alon Lazarus | Director | Cambridge, MA |
| Nima Farzan | Director | Thousand Oaks, CA |
| Julius Knowles | Director | Somerville, MA |
| Ran Nussbaum | Director | New York, NY |
| Zafrira Avnur | Director | Framingham, MA |
| Keith Regnante | Executive Officer | Lexington, MA |
| Jenn Lachey | Executive Officer | Lexington, MA |
| Claudia Ordonez | Executive Officer | Lexington, MA |
| Jasbir Seehra | Director | Lexington, MA |
| Jasbir Seehra | Executive Officer | Lexington, MA |
Other filings by this issuer (4)
More